You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 40 No. 12, December 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Reliability of Norepinephrine and Major Monoamine Metabolite Measurements in CSF of Schizophrenic Patients

Markku Linnoila, MD, PhD; Philip T. Ninan, MD; Mika Scheinin, MD; Robert N. Waters, MD; Wen-Ho Chang, MD; John Bartko, PhD; Daniel P. van Kammen, MD, PhD

Arch Gen Psychiatry. 1983;40(12):1290-1294.


Abstract



• Concentrations of norepinephrine, 3-methoxy-4-hydroxyphenylglycol, homovanillic acid, and 5-hydroxyindoleacetic acid (5-HIAA) were quantified in the CSF of 28 drug-free schizophrenic patients. Fifteen patients provided more than one drug-free sample on separate occasions. Considerable intraindividual variability over time was found in the concentrations of norepinephrine and these major monoamine metabolites in the repeated samples. This was not explained by assay errors or changes in the patient's global psychosis ratings. The variability in the present sample for CSF 5-HIAA concentrations was almost twice as wide as has been reported for patients with affective disorder. Variables that contribute much of the variability of norepinephrine and major monoamine metabolite concentrations in drug-free CSF samples from schizophrenic patients remain unknown and cannot be controlled.



Author Affiliations



From the Branches of Clinical Psychobiology (Drs Linnoila, Scheinin, and Chang), Biological Psychiatry (Drs Ninan, Waters, and van Kammen), and Theoretical Statistics and Mathematics (Dr Bartko), National Institute of Mental Health, Bethesda, Md.


Footnotes



Accepted for publication Feb 14, 1983.

Reprint requests to National Institute of Mental Health, Room 4S-239, Bldg 10, 9000 Rockville Pike, Bethesda, MD 20205 (Dr Linnoila).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Norepinephrine in Acute Exacerbations of Chronic Schizophrenia: Negative Symptoms Revisited
van Kammen et al.
Arch Gen Psychiatry 1990;47:161-168.
ABSTRACT  

Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype
Ko et al.
Arch Gen Psychiatry 1988;45:842-846.
ABSTRACT  

Physiological Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia: III. A New Cohort and Evidence for a Monoaminergic Mechanism
Weinberger et al.
Arch Gen Psychiatry 1988;45:609-615.
ABSTRACT  

Noradrenergic Function in Schizophrenia
Glazer et al.
Arch Gen Psychiatry 1987;44:898-904.
ABSTRACT  

Serotonin and 5-Hydroxyindoleacetic Acid in Brains of Suicide Victims: Comparison in Chronic Schizophrenic Patients With Suicide as Cause of Death
Korpi et al.
Arch Gen Psychiatry 1986;43:594-600.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.